Role of 18F-FDG PET/CT in detecting recurrent gallbladder carcinoma

Clinical Nuclear Medicine

Volumn 37, Issue 5, 2012, Pages 431-435

  Kumar, Rakesh ^a   Sharma, Punit ^a   Kumari, Anita ^a   Halanaik, Dhanapathi ^a   Malhotra, Arun ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

gallbladder carcinoma; PET CT; recurrence

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; MALE; METASTASIS; PREDICTOR VARIABLE; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; GALLBLADDER TUMOR; MIDDLE AGED; RADIOGRAPHY; SCINTISCANNING; STANDARD; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; GALLBLADDER NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; REFERENCE STANDARDS;

EID: 84859645576     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31824d24c4     Document Type: Article

References (33)

1. Shi JS, Wang JS, Liu G, et al. Early diagnosis of primary gallbladder carcinoma. HBPD Int. 2002;1:273-275. (Pubitemid 36748218)
2. SEER database. Available at: http://seer.cancer.gov/. Accessed July 6, 2010.
3. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
4. Lazcano-Ponce EC, Miquel JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. Cancer J Clin. 2001;51:349-364. (Pubitemid 34232782)
5. Leonard GD, O'Reilly EM. Biliary tract cancers: current concepts and controversies. Expert Opin Pharmacother. 2005;6:211-223. (Pubitemid 40305335)
6. Levy AD, Murakata LA, Rohrmann CA. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics. 2001;21:295-314. (Pubitemid 33707760)
7. Yildrim E, Celen O, Gulben K, et al. The surgical management of incidental gallbladder carcinoma. Eur J Surg Oncol. 2005;31:45-52. (Pubitemid 40103924)
8. Misra S, Chaturvedi A, Misra NC, et al. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167-176. (Pubitemid 36322307)
9. Muratore A, Amisano M, Vigano L, et al. Gallbladder cancer invading the perimuscular connective tissue: results of reresection after prior non-curative operation. J Surg Oncol. 2003;83:212-215. (Pubitemid 36936005)
10. Ogura Y, Mizumoto R, Isaji S, et al. Radical operations for carcinoma of the gallbladder: present status in Japan. World J Surg. 1991;15:337-343.
11. Ouchi K, Suzuki M, Tominaga T, et al. Survival after surgery for cancer of the gallbladder. Br J Surg. 1994;81:1655-1657. (Pubitemid 24349947)
12. Matsumoto Y, Fujii H, Aoyama H, et al. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg. 1992;163:239 -245.
13. Wagholikar GD, Behari A, Krishnani N, et al. Early gallbladder cancer. J Am Coll Surg. 2002;194:137-141. (Pubitemid 34118869)
14. Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior non curative intervention. Ann Surg. 2000;232:557-569.
15. Behari A, Sikora SS, Wagholikar GD, et al. Long term survival after extended resections in patients with gallbladder cancer. J Am Coll Surg. 2003;196:82-88. (Pubitemid 36070998)
16. Miyazaki M, Ito H, Nakagawa K, et al. Does aggressive surgical resection improve the outcome in advanced gallbladder carcinoma? Hepatogastroenterology. 1999;46:2128-2132. (Pubitemid 29454056)
17. de Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. New Engl J Med. 1999;341:1368-1379.
18. Khan SA, Davidson BR, Goldin R, et al. British Society of Gastroenterology. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51:1-9.
19. Chaube A, Tewari M, Singh U, et al. CA 125: a potential tumor marker for gallbladder cancer. J Surg Oncol. 2006;93:665-669. (Pubitemid 43855697)
20. Shukla PJ, Barreto SG, Arya S, et al. Does PET-CT scan have a role prior to radical re-resection for incidental gallbladder cancer? HPB. 2008;10:439-445.
21. Petrowsky H, Wildbrett P, Husarik DB, et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol. 2006;45:43-50. (Pubitemid 43850623)
22. Koh T, Taniguchi H, Yamaguchi A, et al. Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluorodeoxyglucose (FDG-PET). J Surg Oncol. 2003;84:74-81. (Pubitemid 37247912)
23. Rodriguez-Fernandez A, Gomez-Rio M, Llamas-Elvira JM, et al. Positron emission tomography with fluorine-18-fluoro-2- deoxy-D-glucose for gallbladder cancer diagnosis. Am J Surg. 2004;188:171-175. (Pubitemid 38916738)
24. Koh T, Taniguchi H, Kunishima S, et al. Possibility of differential diagnosis of small polypoid lesions in the gallbladder using FDG-PET (case report). Clin Positron Imaging. 2000;3:213-218.
25. Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Dual time-point 18F-FDG PET for the evaluation of gallbladder carcinoma. J Nucl Med. 2006;47:633-638. (Pubitemid 46768464)
26. Anderson CD, Rice MH, Pinson CW, et al. Fluordeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg. 2004;8:90-97. (Pubitemid 38117282)
27. Corvera CU, Blumgart LH, Akhurst T, et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg. 2008;206:57-65. (Pubitemid 350267250)
28. Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: Implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689-1700. (Pubitemid 37238626)
29. Takada T, Amano H, Yasuda H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? a phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95:1685-1695.
30. Wang SJ, Fuller CD, Kim JS, et al. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol. 2008;26:2112-2117.
31. Aramaki M, Matsumoto T, Shibata K, et al. Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma. Hepatogastroenterology. 2004;51:1609-1611. (Pubitemid 39389742)
32. Kalra N, Suri S, Gupta R, et al. MDCT in the Staging of Gallbladder Carcinoma. AJR. 2006;186:758-762. (Pubitemid 46100260)
33. Lee SW, Kim HJ, Park JH, et al. Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterology. 2010;45:560-566.